In addition to controlling the cells’ self-renewal capacity, Cur combined with cisplatin directly induces death in the highly migratory CSC subpopulation by changing cyclin D1 and p21 expression while enhancing NSCLC sensitivity to cisplatin [79]. The gene discussed is CCND1; the disease is non-small cell lung carcinoma.